Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Holdings -- Ignore unavailable to you. Want to Upgrade?

To: tommysdad who wrote (94)	1/16/1998 5:35:00 PM
From: Mike Heimbuch	Read Replies (1) \| Respond to of 224

Thanks for the reply I think I have it narrowed to Johnson + J. , or Lilly - though I could be wrong. Been doing some sleuthing into the Carib phase 3 - and the China thing through a pharma newsletter over there. I am impressed at this point by one thing - An unconventional approach by the company has still netted them a prominent R+D - drug marketing specialist - who has seen enough to put his name behind further inquiry - and that other major pharmas are indeed interested in DIAB MH